Currently the price is 15,90$, In this post we are going to talk about the listed company Avalo Therapeutics Inc, its leaders are Garry Arthur Neil (Chief Scientific Officer), H. Jeffrey Wilkins (Chief Medical Officer), Lisa Hegg (Vice President-Research & Development Programs), Michael F. Cola (Chairman & Chief Executive Officer), Pericles Calias (Chief Scientific Officer, Head-R&D), Schond L. Greenway (Chief Financial Officer & Treasurer), Younok Dumortier Shin (Chief Technology Officer), they lead it to work in Biotechnology: Pharmaceutical Preparations especially in the North America region.

Today this action begins with yesterday's closing price, desconocido$.

The current range on the same day is from 15,61$ - 17,42$, with a percentage difference of 16,52$ quite wide that helps to be able to do day trading.

Their latest annual data shows an income of desconocido.

The last registered opening is of desconocido.

One of the most interesting values to assess whether the price of a share is low or high is the minimum and maximum price of the last 52 weeks, in this case it has varied between 0,00$ and 0,00$.

EPS is the net profit that the company has obtained, after paying taxes, divided by the number of total shares it has in circulation. This value is higher the better the company has done, although with some nuances since it can increase if the number of shares for sale decreases, or it can decrease if things that have happened in just a few months are charged annually. For this action the BPA is [BPA].